Anti-ARF1 + ARF3 antibody [EPR8304(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal ARF1 antibody. Suitable for IHC-P, WB and reacts with Human, Recombinant full length protein - Human samples. Cited in 4 publications.
View Alternative Names
ADP-ribosylation factor 1, ARF1, ADP-ribosylation factor 3, ARF3
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARF1 + ARF3 antibody [EPR8304(B)] (AB129003)
ab129003, at 1/50 dilution, staining ARF3 in paraffin-embedded Human stomach tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-ARF1 + ARF3 antibody [EPR8304(B)] (AB129003)
Blocking and diluting buffer : 5% NFDM/TBST
Human ARF-1 recombinant protein, (Cat# : ab123538 )
Human ARF-3 recombinant protein, (Cat# : ab113581 )
All lanes:
Western blot - Anti-ARF1 + ARF3 antibody [EPR8304(B)] (ab129003) at 1/20000 dilution
Lane 1:
Full length human ARF-1 recombinant protein at 0.015 µg
Lane 2:
Full length human ARF-3 recombinant protein at 0.015 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 20 kDa
Observed band size: 23 kDa
false
Exposure time: 3min
- WB
Unknown
Western blot - Anti-ARF1 + ARF3 antibody [EPR8304(B)] (AB129003)
All lanes:
Western blot - Anti-ARF1 + ARF3 antibody [EPR8304(B)] (ab129003) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Lane 3:
Human fetal brain lysate at 10 µg
Lane 4:
Raji cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 20 kDa
Observed band size: 20 kDa
false
Related conjugates and formulations (1)
-
Anti-ARF1+ARF3 antibody [EPR8304(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ARF1 and ARF3 are significant in the intracellular trafficking of proteins and lipids. The proteins are part of the coatomer protein complex (COPI) important for retrograde transport from the Golgi to the endoplasmic reticulum. By recruiting coat proteins to the Golgi membranes ARF1 and ARF3 facilitate the sorting and packaging of cargo molecules into transport vesicles. This process sustains the maintenance of organelle identity and the dynamics of membrane remodeling.
Pathways
ARF1 and ARF3 are involved in key cellular pathways particularly those related to vesicular trafficking and membrane dynamics. They participate in the COPI and clathrin-mediated pathways. Through these pathways ARF1 interacts with proteins like PDZD8 while ARF3 works with proteins involved in primary cilia formation. These interactions underline their integrative role in maintaining proper cellular organization and communication.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:675 PubMed41053099
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of lipid research 64:100362 PubMed36958722
2023
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 24:40 PubMed35681213
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:714799 PubMed34721381
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com